ConductScience.org, home

Paper971694

Plasma hormones in patients with advanced breast cancer treated with tamoxifen.

Golder MP and 6 others. Eur J Cancer (1965), 1976. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. Plasma hormones in patients with advanced breast cancer treated with tamoxifen. Papers, record 971694. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/971694

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma hormones in patients with advanced breast cancer treated with tamoxifen.
PubMed
Journal
Eur J Cancer (1965)
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
4.03
iCite
Revised in PubMed
2019-09-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Golder MPM P
2Phillips MEM E
3Fahmy DRD R
4Preece PEP E
5Jones VV
6Henk JMJ M
7Griffiths KK

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
EstradiolMajor topic
Gonadotropins, PituitaryMajor topic
StilbenesMajor topic
TamoxifenMajor topic
Aged
Female
Follicle Stimulating Hormone
Humans
Luteinizing Hormone
Middle Aged
Prolactin
Time Factors

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
7204884The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.J Endocrinol Invest1980https://conductscience.org/library/papers/7204884PubMed
7104195Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.Br J Cancer1982https://conductscience.org/library/papers/7104195PubMed
6684948Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6684948PubMed
6682819Male gonadal function in coeliac disease: 2. Sex hormones.Gut1983https://conductscience.org/library/papers/6682819PubMed
6540595Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.Br J Cancer1984https://conductscience.org/library/papers/6540595PubMed
6184101Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.Breast Cancer Res Treat1982https://conductscience.org/library/papers/6184101PubMed
837137Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.Br Med J1977https://conductscience.org/library/papers/837137PubMed
352663Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.Drugs1978https://conductscience.org/library/papers/352663PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/971694

GET https://conductscience.org/api/papers/v1/971694/authors